Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979950 · ClinicalTrials.gov registry record
Contraception for Solid Organ Transplant Patients: Utilizing Social Media
A clinical trial of Contraception and Contraceptive Usage, sponsored by University of California, San Diego.
- Completed
- Registry status
- 52
- Enrollment target
- 1
- Study location
NCT03979950: Completed study of Contraception and Contraceptive Usage, sponsored by University of California, San Diego.
NCT03979950 is a study of Contraception and Contraceptive Usage that has completed, run by University of California, San Diego. The registered enrollment target is 52 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03979950, a study of Contraception and Contraceptive Usage, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use an electronic survey to explore Solid Organ Transplant patients' contraceptive knowledge and counseling. The results from this survey will be used to help identify awareness gaps to potentially develop targeted interventions for comprehensive education.
Primary Outcome
The survey questionnaire asks multiple-choice questions about (1) available contraceptive methods, (2) the safety profile of methods for women with transplant histories, and (3) the teratogenic risks of post-transplant medications.
Conditions Studied
Interventions
- BEHAVIORAL Survey
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2020-12-01 |
What the finished NCT03979950 record still lists
NCT03979950 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03979950 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03979950 about?
NCT03979950 is a clinical study titled "Contraception for Solid Organ Transplant Patients: Utilizing Social Media". The purpose of this study is to use an electronic survey to explore Solid Organ Transplant patients' contraceptive knowledge and counseling. The results from this survey will be used to help identify awareness gaps to potentially develop targeted interventions for comprehensive education.
What is the current status of trial NCT03979950?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2018-01-18. Estimated completion is 2020-12-01.
What conditions does trial NCT03979950 study?
This clinical trial studies the following conditions: Contraception, Contraceptive Usage, Contraception Behavior, Reproductive Health.
What interventions are being tested in trial NCT03979950?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT03979950?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03979950 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03979950's enrollment target sits among peer trials
52 50th of 72 higher than 21 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI